Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329251
Status:
COMPLETED
Last Update Posted:
2006-05-24
First Post:
2006-05-22
Brief Title:
Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV
Sponsor:
Hospital Clinic of Barcelona
Organization:
Hospital Clinic of Barcelona
Study Overview
Official Title:
Study of the Influence of Immunological Repeated Stimuli With Commercial Vaccines Over the Viral Load VL Resistance Development and Specific Immunological Response Against HIV in Early Stage HIV Patients With Undetectable VL After HAART
Status:
COMPLETED
Status Verified Date:
2006-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether an immunization schedule is beneficial to HIV-infected patients with CD4 recount over 500 cellsmm3 and undetectable viral load
Detailed Description:
As HIV-infected patients are considered immunocompromised it is generally recommended that they have to receipt appropriate vaccines However data are conflicting concerning potential harmful effects following the administration of commercial vaccines in HIV-infected patients Transient increases blips in the viral load have been described associated with a single dose of vaccine with the potential risk of developing resistance to HAART On the other hand there has been described that patients with blips can have an increase in HIV-specific immune responses which may help to improve the viral control
Comparison We have performed a clinical trial to evaluate the effect of a vaccination program in successfully treated HIV-infected adults on HAART compared to placebo
Comparison We have performed a clinical trial to evaluate the effect of a vaccination program in successfully treated HIV-infected adults on HAART compared to placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| VAC-01 | None | None | None |